Live Clinical and Health Research

Research studies currently recruiting

We’re keen to grow and develop Clinical and Health Research into all health areas within HWHCT. Please see below and click through for research studies that are currently recruiting participants and how you can get involved. For further information please email us.

PAMORAMIC: NEW Urgent Public Health clinical trial investigating antiviral treatments for people with COVID-19 that can be taken at home. For further information please click on the COVID-19 link below (December 2021)

Our performance in delivering research

The Government aims to increase the number of patients who have the opportunity to participate in good quality research.

To support this, the Department of Health assesses the performance of NHS providers in setting up and engaging patients in clinical trials. The Trust is required to publish its performance four times a year.

The Trust is measured on two indicators; one is the time it has taken the Trust to start a clinical trial, and the second is its delivery of commercial clinical research, to the agreed timescales and targets.

Please click on the link below to view our performance;

https://ccfctp.nihr.ac.uk/public-trustsubmissions/worcestershire-health-and-care-nhs-trust-998

 

Mental Health

Alzheimer’s including dementia

We don't have any studies in this field at the moment. However please go to the Join Dementia Research webpage to find out more about their service which allows people to register their interest in participating in dementia research and be matched to suitable studies.

National Centre for Mental Health (NCMH)

What is this study about?

We are trying to understand why some people experience problems with their mental health. The purpose of this study is to collect information and samples for genetic, biological, psychological and clinical research. This will allow us to look for genes and other factors which make some people more likely than others to become ill. We hope that our study will improve understanding of these conditions and help find better treatments in the future.

Who can take part?

- If you or one of your relatives have experienced a mental illness

- If neither you nor your relatives have experienced a mental illness

By comparing information from people who have experienced a mental illness with information from people who have not experienced such problems, we hope to learn more about the factors that may make some people more susceptible to these illnesses.

What is involved?

- A meeting with a member of the research team to complete a 30-60 minute assessment including patient consent

- A blood sample or if taking blood is not possible a saliva sample

- Look at your medical records to gain further details about the kinds of symptoms and treatments you have had. With permission to look at your records in the future to see if there has been any change in your health.

- May ask you if any other members of your family would like to take part as this enables us to acquire a wide base of family genetic information. However, we would only contact your relatives with your full agreement.

 

 

Anxiety & Depression

GLAD (Genetic Links to Anxiety and Depression) study logoGLAD: Genetic Links to Anxiety and Depression - now open until 30.11.22

What is this study about?

Depression and anxiety are the most common mental health disorders worldwide. In the UK, 1 in 3 people will experience symptoms during their lifetime. The GLAD Study aims to better understand depression and anxiety in order to find effective treatments and improve the lives of people experiencing these disorders.

The study explores how our genes and the environment influence the development of anxiety and depression in order to improve future treatment. Involvement in GLAD also involves joining the NIHR Mental Health BioResource, a central library of information about people’s health made up of genetic and clinical data.

Who can take part?

Anyone over the age of 16 who has experienced symptoms of anxiety or depression in their lifetime. There is no age limit, and participants can be NHS patients, parents/relatives/carers of patients and self-referred volunteers.

What is involved?

There are 4 simple steps to signing up to the GLAD Study:

  1. Register on the website and read the information sheet
  2. Provide consent
  3. Complete a 30 minute questionnaire to see if you are eligible
  4. Send a saliva DNA sample through the post

Once you have signed up to the GLAD Study, you will be able to see information on the website about a number of optional questionnaires or other research studies that are being carried out. You will be able to choose to take part in these studies should you wish to.

You can stop taking part in the GLAD Study at any time.

How to get involved?

To access the study go online here to learn more and to sign up. Remember to say you heard about the survey through Herefordshire and Worcestershire Health and Care NHS Trust.

BiPolar and Related Mood Disorders

Molecular

What is this study about?

Look for genes and other factors, which make some people more likely than others to become ill. Improve understanding of mood disorders and future treatments.

Who can take part?

- Aged 18+ and can give informed consent

- Experienced one or more episodes of mania/hypomania at any time in the past

What is involved?

- 30-40 minute interview

- 30 minute questionnaire

- provide a blood sample

 

Bipolar Disorder Research Network Logo Bipolar Disorder Research Network (BDRN)

What is this study about?

The BDRN team are conducting research into the causes of bipolar disorder and related mood disorders. The main aim is to identify susceptibility genes for bipolar and other related mood disorders. The study is hoping to improve the understanding of the causes of mood disorders and help find better treatments for the future.

Who can take part?

Participants will be eligible if they are aged 18+, have had a diagnosis of bipolar disorder (or a related mood disorder) and have experienced one or more episodes of mania or hypermania at any time in the past.

What is involved?

Taking part involves an interview (either in person or over the phone), completing a set of questionnaires and providing a blood sample.

Learning Difficulties

Just opened:

BEAMS-ID (Behavioural Interventions to Treat Anxiety in Adults with Autism and Moderate to Severe Intellectual Disabilities) study logoBehavioural Interventions to Treat Anxiety in Adults with Autism and Moderate to Sever Intellectual Disabilities

What is this study about?

To adapt an existing therapy for anxiety disorders that was developed for autistic adults without intellectual disabilities.

Who can take part?

Adults with severe intellectual disabilities

What is involved?

- Our Intervention Adaptation Group (IAG) will be comprised of 6 to 8 key stakeholders who will be representatives from our PPI partners, carers and family members, people with autism and/or intellectual disabilities, and clinicians, along with members of the research team.

- An online survey of existing community-based services within the UK to characterise Treatment as Usual (TAU)

- Single-arm non-randomised feasibility study of behavioural intervention plus TAU for the treatment of anxiety disorders amongst people with autism who have moderate to severe intellectual disabilities, and the use of qualitative and quantitative research methods to help address key components of feasibility. Recruitment will be open to participants with autism and moderate to severe intellectual disabilities who have anxiety disorders within England.

 

STRATA - SerTRaline for AnxieTy in adults with Autism

What is this study about?

Whether the medication, sertraline, is an effective treatment for anxiety in adults with a diagnosis of autism

Who can take part?

- Aged 18 +

- Have a diagnosis of autism & experience anxiety

- Informed consent

What is involved?

- Taking sertraline or a placebo for a year

- Completing 4 questionnaires at 4 points during this year

- £10 voucher paid on completion

 

Making positive moves

What is this study about?

Finding out what support people with Learning Disabilities (LD) need to remain living in the community after moving out of hospital under the Transforming Care (TC) Programme

Who can take part?

- Mild to moderate LD

- Aged 18+

- Have capacity to give consent

- Are under the care of a TC team or a LD community team

- Have moved from a mental health hospital setting into the community since TC began

What is involved?

2 in-depth semi-structured initial interviews followed by a further 2 interviews a year later

Perinatal

NCMH (National Centre for Mental Health) logoMaternal Wellbeing, Mental Health, and Life Experience

What is this study about?

To explore the factors that may have an effect in pregnancy and in the first year after childbirth i.e. exposure to certain life events and the effects of COVID-19 on the perinatal period.

Who can take part?

ALL women aged 18 or over who are currently within the perinatal period (currently pregnant or up to 1-year postpartum)

What is involved?

- Basic assessment online

- 2 short follow up questionnaires – date for when these are completed is dependent on when the lady was recruited either when pregnant or postnatally

To find out more please click here.

Psychosis including Schizophrenia

IPPACT - Improving prediction of psychosis in ARMS using a clinically useful prognostic tool

What is this study about?

Improve prediction in the at-risk group for future services to provide better support.

Who can take part?

- Mental healthcare professionals

What is involved?

- Anonymised data to track how people are doing after a year.

- Interview after a year

 

Coming soon – opening 2022

ADEPP (Antidepressant for the prevention of DEPression following first episode Psychosis) study logo ADEPP: Antidepressant for the prevention of DEPression following first episode Psychosis trial

What is this study about?

The aim of the ADEPP trial is to establish the effectiveness and cost effectiveness of an antidepressant medication (sertraline) for the prevention of a depressive episode following first episode psychosis (FEP). The study aims to recruit up to 508 participants over a period of 32 months from Early Intervention in Psychosis Services in the NHS Trusts across the UK.

Who can take part?

Patients aged between 18-35 years of age, diagnosed with FEP and within 3 months of initial treatment for FEP.

What is involved?

This is a multi-centre randomised, double-blind, placebo controlled trial with an internal pilot study.

To find out more please contact us

COVID-19

NEW Urgent Public Health clinical trial (Dec 2021):

PAMORAMIC

What is this study about?

PAMORAMIC is a new Urgent Public Health clinical trial which aims to find antiviral treatments which can be taken at home to improve symptoms and reduce hospital admissions for people with current COVID-19 symptoms.
Who can take part?

  • People aged 50 or over or 18-49 with an underlying health condition
  • Have received a positive PCR test result in the last 5 days

What is involved?

  • A few daily questions to answer via the PANORAMIC website for 28 days
  • Contact by the study team 3 and 6 months after you started the trial to see if you have any long covid symptons
  • If randomised to receive the anitviral drug, taking this drug 
  • You can sign-up for the PANORAMIC trial today here: http://panoramictrial.org

ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) Clinical Characterisation Protocol (CCP) for Severe Emerging Infection - study currently paused here at HWHCT

What is this study about?

This is a study recruiting hospitalised cases of confirmed 2019 novel coronavirus infection. Standardised clinical data is being collected to improve patient care and inform the public health response.

Who can take part?

Anyone over the age of 18 who has been hospitalised with Covid 19.

What is involved?

Collecting standard clinical date for a period of time to analyse the recovery from COVID 19.

 

Health and Wellbeing

See yourself differently (SYD) for NHS study

What is this study about?

Explore the benefits of the ‘SYD’ conversational health app which focuses on promoting good health. To establish how SYD can measure and potentially improve key aspects of general Quality of Life, such as physical health, psychological health, social relationships and environment, specifically for NHS staff.

Who can take part?

  • Be an active NHS employee with NHS email address
  • Aged 18+ and own a smart phone

Have mild-moderate levels of anxiety or depressive symptoms as per the HADS (Hospital Anxiety and Depression Scale)

What is involved?

  • Engage with the SYD application on your smartphone
  • Complete study assessments involving questions regarding your quality of life and wellbeing using a study website
  • Click here for further information